Total stock-based compensation expense recognized in the condensed consolidated statements of operations was as follows (in thousands):


	Three Months Ended				Six Months Ended
	July 31, 2025		July 31, 2024		July 31, 2025		July 31, 2024
Cost of revenue	$	222	$	281	$	453	$	541
Sales and marketing		452		1,000		1,155		1,979
Research and development		978		1,403		2,098		2,740
General and administrative		1,983		1,911		3,865		3,698
Total stock-based compensation expense	$	3,635	$	4,595	$	7,571	$	8,958

As of July 31, 2025, there was $27.1 million of unrecognized compensation expense related to unvested RSUs, stock options and stock purchase rights under the ESPP, which is expected to be recognized over a weighted-average vesting period of approximately 2.7 years.